226 related articles for article (PubMed ID: 26011119)
1. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
Roland CL; Ross MI; Hall CS; Laubacher B; Upshaw J; Anderson AE; Lucci A
Melanoma Res; 2015 Aug; 25(4):335-41. PubMed ID: 26011119
[TBL] [Abstract][Full Text] [Related]
2. Circulating melanoma cells and survival in metastatic melanoma.
Rao C; Bui T; Connelly M; Doyle G; Karydis I; Middleton MR; Clack G; Malone M; Coumans FA; Terstappen LW
Int J Oncol; 2011 Mar; 38(3):755-60. PubMed ID: 21206975
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
[TBL] [Abstract][Full Text] [Related]
4. Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
Lucci A; Hall CS; Patel SP; Narendran B; Bauldry JB; Royal RE; Karhade M; Upshaw JR; Wargo JA; Glitza IC; Wong MKK; Amaria RN; Tawbi HA; Diab A; Davies MA; Gershenwald JE; Lee JE; Hwu P; Ross MI
Clin Cancer Res; 2020 Apr; 26(8):1886-1895. PubMed ID: 32015020
[TBL] [Abstract][Full Text] [Related]
5. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases.
Curry BJ; Myers K; Hersey P
J Clin Oncol; 1999 Aug; 17(8):2562-71. PubMed ID: 10561323
[TBL] [Abstract][Full Text] [Related]
6. The detection of circulating melanoma cells correlates with tumour thickness and ulceration but is not predictive of metastasis for patients with primary melanoma.
Hanekom GS; Stubbings HM; Johnson CA; Kidson SH
Melanoma Res; 1999 Oct; 9(5):465-73. PubMed ID: 10596913
[TBL] [Abstract][Full Text] [Related]
7. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance.
Nezos A; Lembessis P; Sourla A; Pissimissis N; Gogas H; Koutsilieris M
Clin Chem Lab Med; 2009; 47(1):1-11. PubMed ID: 19055471
[TBL] [Abstract][Full Text] [Related]
8. Circulating melanoma cells as a potential biomarker to detect metastasis and evaluate prognosis.
Hida T; Yoneta A; Wakamatsu K; Yanagisawa K; Ishii-Osai Y; Kan Y; Kato J; Yamashita T
Australas J Dermatol; 2016 May; 57(2):145-9. PubMed ID: 26931184
[TBL] [Abstract][Full Text] [Related]
9. Utility of tests for circulating melanoma cells in identifying patients who develop recurrent melanoma.
Curry BJ; Myers K; Hersey P
Recent Results Cancer Res; 2001; 158():211-30. PubMed ID: 11092049
[TBL] [Abstract][Full Text] [Related]
10. Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
Joshi P; Jacobs B; Derakhshan A; Moore LR; Elson P; Triozzi PL; Borden E; Zborowski M
Oncotarget; 2014 May; 5(9):2450-61. PubMed ID: 24811334
[TBL] [Abstract][Full Text] [Related]
11. Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression.
Reid AL; Millward M; Pearce R; Lee M; Frank MH; Ireland A; Monshizadeh L; Rai T; Heenan P; Medic S; Kumarasinghe P; Ziman M
Br J Dermatol; 2013 Jan; 168(1):85-92. PubMed ID: 23013138
[TBL] [Abstract][Full Text] [Related]
12. Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
Koyanagi K; O'Day SJ; Gonzalez R; Lewis K; Robinson WA; Amatruda TT; Wang HJ; Elashoff RM; Takeuchi H; Umetani N; Hoon DS
J Clin Oncol; 2005 Nov; 23(31):8057-64. PubMed ID: 16258104
[TBL] [Abstract][Full Text] [Related]
13. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients.
Farthmann B; Eberle J; Krasagakis K; Gstöttner M; Wang N; Bisson S; Orfanos CE
J Invest Dermatol; 1998 Mar; 110(3):263-7. PubMed ID: 9506446
[TBL] [Abstract][Full Text] [Related]
14. Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression.
Rapanotti MC; Viguria TMS; Spallone G; Terrinoni A; Rossi P; Costanza G; Campione E; Lombardo P; Pathirannehalage CD; Orlandi A; Bernardini S; Bianchi L
Cancer Treat Res Commun; 2020; 25():100262. PubMed ID: 33338742
[TBL] [Abstract][Full Text] [Related]
15. Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes.
Porter GA; Abdalla J; Lu M; Smith S; Montgomery D; Grimm E; Ross MI; Mansfield PF; Gershenwald JE; Lee JE
Ann Surg Oncol; 2001 Mar; 8(2):116-22. PubMed ID: 11258775
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.
Mellado B; Colomer D; Castel T; Muñoz M; Carballo E; Galán M; Mascaró JM; Vives-Corrons JL; Grau JJ; Estapé J
J Clin Oncol; 1996 Jul; 14(7):2091-7. PubMed ID: 8683241
[TBL] [Abstract][Full Text] [Related]
17. Predicting Metastasis in Melanoma by Enumerating Circulating Tumor Cells Using Photoacoustic Flow Cytometry.
Edgar RH; Tarhini A; Sander C; Sanders ME; Cook JL; Viator JA
Lasers Surg Med; 2021 Apr; 53(4):578-586. PubMed ID: 32557708
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of PCR-positive mRNA markers in peripheral blood and regional nodes of malignant melanoma patients. Melanoma Cooperative Group.
Palmieri G; Pirastu M; Strazzullo M; Ascierto PA; Satriano SM; Motti ML; Botti G; Mozzillo N; Castello G; Cossu A; Lissia A; Tanda F
Recent Results Cancer Res; 2001; 158():200-3. PubMed ID: 11092047
[TBL] [Abstract][Full Text] [Related]
19. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
[TBL] [Abstract][Full Text] [Related]
20. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.
Rapanotti MC; Cugini E; Nuccetelli M; Terrinoni A; Di Raimondo C; Lombardo P; Costanza G; Cosio T; Rossi P; Orlandi A; Campione E; Bernardini S; Blot-Chabaud M; Bianchi L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]